Abstract
Our previous studies have shown that the treatment of human colorectal cancer cells HCT-116 with non-toxic concentrations of antineoplastic drugs such as paclitaxel (PAC) or doxorubicin (DOX) induces changes in the transcription of a wide variety of genes. The treatment was also able to make tumor cells more immunogenic and more sensitive to the activity of cytotoxic T cells generated in …